Michael A. Byrne active positions
| Companies | Position | Start | End |
|---|---|---|---|
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Director of Finance/CFO | 1999-12-31 | - |
| Corporate Secretary | 1999-12-31 | - |
Career history of Michael A. Byrne
Former positions of Michael A. Byrne
| Companies | Position | Start | End |
|---|---|---|---|
| Hyal Pharmaceutical Corp. | Corporate Officer/Principal | - | - |
Statistics
International
| Canada | 3 |
Operational
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
| Hyal Pharmaceutical Corp. | Health Technology |
- Stock Market
- Insiders
- Michael A. Byrne
- Experience
